IDXX vs. MDT: IDEXX Laboratories vs. Medtronic Stock Comparison

Company Profile

IDEXX Laboratories (IDXX) and Medtronic (MDT) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while Medtronic (MDT) is defensive at 0.53 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Medtronic (MDT) is heavily traded at around 16.48M shares per day, whereas IDEXX Laboratories (IDXX) sees a more moderate 564.80K — larger orders in the latter may require more patience and tighter control over order sizing.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

IDEXX Laboratories (IDXX) at 68.93% clears its industry range for ROE, a sharper capital-efficiency signal than Medtronic (MDT) at 10.65%, which is closer to a typical peer reading.

For every dollar of sales, both IDEXX Laboratories (IDXX) at 25.36% and Medtronic (MDT) at 13.93% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both IDEXX Laboratories (IDXX) at 33.14% and Medtronic (MDT) at 19.33% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both IDEXX Laboratories (IDXX) at 10.42% and Medtronic (MDT) at 8.43% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Both IDEXX Laboratories (IDXX) at 22.59% and Medtronic (MDT) at 3.32% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Growth Metrics

Financial Strength

Medtronic (MDT) at 2.07 keeps current ratio within its industry’s typical mid-range, while IDEXX Laboratories (IDXX) at 1.19 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for IDXX.

Both IDEXX Laboratories (IDXX) at 0.52 and Medtronic (MDT) at 0.55 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

IDEXX Laboratories (IDXX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Medtronic (MDT) reports a yield of 2.72%, ranking against industry peers normally.

IDEXX Laboratories (IDXX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Medtronic (MDT) reports a payout of 70.02%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both IDEXX Laboratories (IDXX) at 45.56 and Medtronic (MDT) at 25.01 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

Medtronic (MDT) at 3.47 prices around its industry’s typical P/S ratio, while IDEXX Laboratories (IDXX) at 11.42 clears its benchmark range — IDXX looks notably rich on sales.

Medtronic (MDT) at 2.59 sits near its industry’s typical P/B ratio, while IDEXX Laboratories (IDXX) at 28.50 prices above its benchmark range — IDXX looks rich relative to book.

Valuation Metrics